Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population

Genes and Immunity

Volumn 12, Issue 7, 2011, Pages 552-558

  Fletcher, G J ^a   Samuel, P ^a   Christdas, J ^a   Gnanamony, M ^a   Ismail, A M ^a   Anantharam, R ^a   Eapen, C E ^a   Chacko, M P ^a   Daniel, D ^a   Kannangai, R ^a   Abraham, P ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

HBV outcome; HLA; TNF

Indexed keywords

HLA ANTIGEN; TUMOR NECROSIS FACTOR;

ARTICLE; CHRONICITY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HLA SYSTEM; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS B; HEPATITIS B, CHRONIC; HLA ANTIGENS; HLA-DRB1 CHAINS; HUMANS; INDIA; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 80054858993     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2011.32     Document Type: Article

References (51)

1. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000; 61: 362-366. (Pubitemid 30368539)
2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107. (Pubitemid 38365759)
3. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745. (Pubitemid 27527771)
4. Datta S. An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J 2008; 5: 156.
5. Pitchappan RM. Castes, migration, immunogenetics and infectious diseases in south India. Community Genet 2002; 5: 157-161. (Pubitemid 35356675)
6. Basu A, Mukherjee N, Roy S, Sengupta S, Banerjee S, Chakraborty M et al. Ethnic India: a genomic view, with special reference to peopling and structure. Genome Res 2003; 13: 2277-2290. (Pubitemid 37265994)
7. Verma G, Dalai P, Bapat M, Rathi P, Abraham P. Familial clustering of hepatitis B infection: study of a family. Indian J Gastroenterol 2003; 22: 22-23. (Pubitemid 36262281)
8. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60.
9. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev 2005; 5: 215-229. (Pubitemid 40364823)
10. Huang CF, Lin SS, Ho YC, Chen FL, Yang CC. The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol 2006; 3: 97-106.
11. Zganiacz A, Santosuosso M, Wang J, Yang T, Chen L, Anzulovic M et al. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest 2004; 113: 401-413. (Pubitemid 38544184)
12. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303-310.
13. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353.
14. D?Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39: 150-154. (Pubitemid 23344817)
15. Zimmerman PA, Guderian RH, Nutman TB. A new TNFA promoter allele identified in South American Blacks. Immunogenetics 1996; 44: 485-486. (Pubitemid 26336395)
16. Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, McKenzie FE, Gribben JG et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998; 52: 359-367. (Pubitemid 28467010)
17. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399. (Pubitemid 27368335)
18. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199. (Pubitemid 27157287)
19. Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV. CD8(+) Tcell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol 2010; 184: 287-295.
20. Chen Y, Wei H, Gao B, Hu Z, Zheng S, Tian Z. Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J Viral Hepat 2005; 12: 38-45. (Pubitemid 40188772)
21. Cavanaugh VJ, Guidotti LG, Chisari FV. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J Virol 1998; 72: 2630-2637. (Pubitemid 28175496)
22. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284: 825-829. (Pubitemid 29291352)
23. Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007; 13: 1770-1787. (Pubitemid 46706009)
24. Balakrishnan K, Pitchappan RM, Suzuki K, Kumar US, Santhakumari R, Tokunaga K. HLA affinities of Iyers, a Brahmin population of Tamil Nadu, South India. Hum Biol 1996; 68: 523-537. (Pubitemid 126447493)
25. Shanmugalakshmi S, Balakrishnan K, Manoharan K, Pitchappan RM. HLA-DRB1, -DQB1 in Piramalai Kallars and Yadhavas, two Dravidian-speaking castes of Tamil Nadu, South India. Tissue Antigens 2003; 61: 451-464. (Pubitemid 36808174)
26. Shankarkumar U, Sridharan B. HLA DRB1 and DQB1 allelic diversity among Nadars: a primitive south Indian Dravidian caste group. Hum Immunol 2004; 65: 847-854. (Pubitemid 39164871)
27. Thursz M. Pros and cons of genetic association studies in hepatitis B. Hepatology (Baltimore, MD) 2004; 40: 284-286. (Pubitemid 39062844)
28. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994; 344: 1194-1195. (Pubitemid 24323710)
29. Wang C, Tang J, Song W, Lobashevsky E, Wilson CM, Kaslow RA. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology (Baltimore, MD) 2004; 39: 978-988. (Pubitemid 38428937)
30. Desombere I, Willems A, Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 1998; 51: 593-604. (Pubitemid 28306463)
31. McDermott AB, Zuckerman JN, Sabin CA, Marsh SG, Madrigal JA. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997; 50: 8-14. (Pubitemid 27273706)
32. McDermott AB, Cohen SB, Zuckerman JN, Madrigal JA. Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine. Vaccine 1999; 17: 330-339. (Pubitemid 28557180)
33. Potter DM. A permutation test for inference in logistic regression with small- and moderate-sized data sets. Stat Med 2005; 24: 693-708. (Pubitemid 40298121)
34. Kim YJ, Lee HS, Yoon JH, Kim CY, Park MH, Kim LH et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet 2003; 12: 2541-2546. (Pubitemid 37220418)
35. Kao PC,Wu JF, Ni YH, Lin YT, Chen HL, Hsu SH et al. Tumour necrosis factor-alpha promoter region polymorphisms affect the course of spontaneous HBsAg clearance. Liver Int 2010; 30: 1448-1453.
36. Skoog T, van?t Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J et al. A common functional polymorphism (C-4A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999; 8: 1443-1449. (Pubitemid 29374077)
37. Tsuchiya N, Tokushige K, Yamaguchi N, Hasegawa K, Hashimoto E, Yamauchi K et al. Influence of TNF gene polymorphism in patients with acute and fulminant hepatitis. J Gastroenterol 2004; 39: 859-866. (Pubitemid 39409667)
38. Li Z, Li HQ, Yan Y, Liu Y, Hao W, Niu JQ et al. Association between genetic polymorphism of tumor necrosis factor and chronic severe hepatitis B in patients]. Zhonghua Yi Xue Za Zhi 2007; 87: 2105-2108. (Pubitemid 350019942)
39. Lu LP, Li XW, Liu Y, Sun GC, Wang XP, Zhu XL et al. Association of -238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. World J Gastroenterol 2004; 10: 1810-1814. (Pubitemid 38931211)
40. Li HQ, Li Z, Liu Y, Li JH, Dong JQ, Gao JR et al. Association of- 238G/A and -857C/T polymorphisms of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection. Biomed Environ Sci 2006; 19: 133-136. (Pubitemid 43901642)
41. Zhu QR, Ge YL, Gu SQ, Yu H, Wang JS, Gu XH et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J (Engl) 2005; 118: 1604-1609. (Pubitemid 41489035)
42. Selvaraj P, Sriram U, Mathan Kurian S, Reetha AM, Narayanan PR. Tumour necrosis factor alpha (-238 and-308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes. Tuberculosis (Edinburgh, Scotland) 2001; 81: 335-341.
43. Amarapurpar DN, Patel ND, Kankonkar SR. HLA class II genotyping in chronic hepatitis B infection. J Assoc Physicians India 2003; 51: 779-781. (Pubitemid 41315500)
44. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
45. Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G et al. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 1996; 23: 1725-1728. (Pubitemid 26342442)
46. Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 2002; 97: 2086-2092.
47. Kubota T, McNamara DM, Wang JJ, Trost M, McTiernan CF, Mann DL et al. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial. Circulation 1998; 97: 2499-2501. (Pubitemid 28294494)
48. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001; 29: E88-E88.
49. Grutters JC, Sato H, Pantelidis P, Lagan AL, McGrath DS, Lammers JW et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002; 165: 1119-1124. (Pubitemid 34415821)
50. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 2005; 21: 263-265. (Pubitemid 40202029)
51. Qin ZS, Niu T, Liu JS. Partition-ligation-expectationmaximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet 2002; 71: 1242-1247. (Pubitemid 35305248)